Kiniksa Pharmaceuticals Ltd. (KNSA) Q1 2024 Earnings Call Transcript
Related Articles
-
Tether Q1 2024 Attestation Reveals Record $4.52 Billion Profits – Altcoins Bitcoin News
Tether, one of the largest cryptocurrency companies, has recently released an attestation of its financial activity corresponding to Q1 2024. Tether registered a record-breaking $4.52 billion in profits, and disclosed its net equity levels, reporting $11.37 billion as of March 31, 2024. Tether issued over $12.5 billion USDT during this period. Tether Attestation Registers Record-Breaking […]
-
Bitfarms Ltd. (NASDAQ:BITF) Expected to Earn Q1 2024 Earnings of ($0.02) Per Share
Bitfarms Ltd. (NASDAQ:BITF – Free Report) – Northland Capmk issued their Q1 2024 earnings per share estimates for shares of Bitfarms in a report issued on Thursday, April 25th. Northland Capmk analyst M. Grondahl anticipates that the company will post earnings per share of ($0.02) for the quarter. The consensus estimate for Bitfarms’ current full-year […]
-
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medi